2005–2015 global analysis of advanced breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the Champalimaud Clinical Center, Lisbon, Portugal, discusses the collaboration between the European School of Oncology and Pfizer for the development of the Global Status of MBC: A Decade Report, an analysis of the global metastatic breast cancer landscape from 2005–2015. Despite showing areas of improvement, unmet needs were identified in patients with metastatic breast cancer, including the need for improved disease awareness, research and patient support.